Part I: 9:00 am – 1:00 pm | Audience Q&A: 2:00 pm – 3:30 pm
Program Chairs: Kymberly Watt, Deniz Balci, James Findlay
With the continuing demand for liver transplantation in the face of a limited organ supply, optimization of care at all stages of the transplant continuum is necessary. This program aims to provide participants with current information on relevant topics across the transplant process to assist in achieving that goal.
9:00 am – 1:00 pm
Session I: Enhancing Access to Transplant
- Living Donor Liver Transplant in the Critically Ill Patients
- When to Use Grafts with Chronic Viral Infections
- [Heart – Liver] Combined Transplants, Does the Patient Really Need a New Liver?
- [Kidney – Liver] Combined Transplants, Does the Patient Really Need a New Liver?
- How Far Can We Go with Social Media as a Source for Liver Donors? [Debate: PRO]
- How Far Can We Go with Social Media as a Source for Liver Donors? [Debate: CON]
Session II: Peri-operative Risk Assessment and Management
- Redefining Cirrhotic Cardiomyopathy and Cardiac Risk: Impact on Peri- and Early Post-Transplant Outcomes
- Extracorporeal Organ Support in ALF and ACLF
- Integrating Palliative Care in the Management of ESLD Patients
- Management of Small for Size in LDLT
Session III: The 10 Years After Transplant
- Transition Clinic from Pediatric to Adult Transplant Hepatology [Debate: PRO by Pediatric Hepatologist]
- Transition Clinic from Pediatric to Adult Transplant Hepatology [Debate: CON by Adult Hepatologist]
- Protecting the End-organs for the Long-haul
- Strategies for Malignancy Prevention in Liver Transplant Recipients
- Infection in the Immunosuppressed Traveler
- Understand the utility of living donor liver transplant, organs with chronic viral infection, machine perfusion and social media in enhancing transplant access.
- Expand the knowledge about evolving concepts in perioperative risk management such as cirrhotic cardiomyopathy and extracorporeal organ support.
- Apply a universal approach to post transplant long term care involving prevention of organ damage and malignancy and infection-related travel risk.
Audience Q&A (Live)
2:00 pm - 3:30 pm